Candida mediated protection against polymicrobial sepsis

念珠菌介导的针对多种微生物败血症的保护作用

基本信息

  • 批准号:
    10583504
  • 负责人:
  • 金额:
    $ 57.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-22 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Project Description The fungal pathogen Candida albicans is the most common cause of invasive fungal infection often originating from outgrowth and invasion from the GI tract. Invasion initially causes intra- abdominal infections (IAI), which are often polymicrobial, and can lead to bloodstream infection and fatal sepsis. When fungal species are involved, mortality rates increase dramatically to 50- 75% depending on patient risk factors. We recently developed an animal model of polymicrobial fungal/bacterial intra-abdominal infection (IAI) with C. albicans (Ca) and Staphylococcus aureus (Sa) that mimics clinical invasive disease (dissemination/sepsis) resulting in 80-100% mortality within 96 h post-inoculation. In contrast, co-infection with the closely related C. dubliniensis (Cd) resulted in <10% mortality. Of particular interest, survivors of Cd/Sa or Cd alone re-challenged with a lethal co-infection (Ca/Sa) resulted in >90% survival. The protective response is sustained long term (up to at least 60 days prior to re-challenge) and is broad-spectrum providing protection against similarly lethal C. tropicalis/Sa and C. krusei/Sa IAI. Surprisingly, the Cd-induced protection against lethal IAI is NOT mediated by adaptive immunity, but instead appears to be through a mechanism of trained innate immunity (non-specific memory mediated by innate cells). Preliminary data indicate that the trained innate response by Cd is mediated by Gr-1+ myeloid derived suppressor cells (MDSC) that have been reported in human sepsis. The concept of trained innate immunity mediated by MDSCs is novel for infectious disease. Accordingly, our central hypothesis is that exposure to low virulence Candida species induce sustained broad spectrum trained innate immune protection against lethal polymicrobial fungal-bacterial sepsis. Mechanistically, we hypothesize that the protective response is mediated by epigenetically re- programed MDSCs during trained innate immunity. The objective of this proposal is to define host and microbial requirements for induction of protective trained innate immunity during polymicrobial sepsis and investigate mechanisms involved in induction, training and effector functions.
项目描述 真菌病原体白色念珠菌是侵袭性真菌感染的最常见原因 通常起源于从胃肠道的生长和侵入。入侵最初导致内部- 腹部感染(IAI),通常是多种微生物,可导致血流感染 和致命的败血症当涉及真菌物种时,死亡率急剧增加到50- 75%取决于患者的风险因素。我们最近开发了一种多微生物的动物模型, 真菌/细菌腹腔感染(IAI),C.白色念珠菌(Ca)和金黄色葡萄球菌 (Sa)模仿临床侵袭性疾病(传播/败血症),导致80-100%的死亡率 接种后96 h内。与此相反,与密切相关的C.都柏林菌(Cd) 死亡率<10%。特别值得注意的是,Cd/Sa或单独Cd的存活者再次激发 致死性共感染(Ca/Sa)导致>90%的存活。保护性反应持续 长期(再激发前至少60天),具有广谱保护作用 对抗同样致命的C. tropicalis/Sa和C. krusei/Sa IAI.令人惊讶的是,镉诱导的 对致死性IAI的保护作用不是由适应性免疫介导的,而是由 通过训练的先天免疫机制(由先天细胞介导的非特异性记忆)。 初步数据表明,镉诱导的先天性反应是由Gr-1+髓样细胞介导的。 衍生的抑制细胞(MDSC),已报告在人类败血症。的概念 由MDSC介导的训练的先天免疫对于感染性疾病是新颖的。因此,我们的 中心假设是暴露于低毒力念珠菌属物种诱导持续广泛的 频谱训练的先天免疫保护,对致命的多微生物真菌-细菌败血症。 从机制上讲,我们假设保护性反应是由表观遗传学上的再- 在训练的先天免疫期间编程MDSC。本提案的目的是确定 宿主和微生物对诱导保护性训练的先天免疫的要求 多微生物脓毒症和研究机制参与诱导,训练和效应 功能协调发展的

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protection against lethal sepsis following immunization with Candida species varies by isolate and inversely correlates with bone marrow tissue damage.
  • DOI:
    10.1128/iai.00252-23
  • 发表时间:
    2023-10-17
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Lilly, Elizabeth A.;Bender, Breah E.;Noverr, Mairi C.;Fidel, Paul L., Jr.
  • 通讯作者:
    Fidel, Paul L., Jr.
Candida-induced granulocytic myeloid-derived suppressor cells are protective against polymicrobial sepsis.
  • DOI:
    10.1128/mbio.01446-23
  • 发表时间:
    2023-10-31
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL L FIDEL其他文献

PAUL L FIDEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL L FIDEL', 18)}}的其他基金

The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
  • 批准号:
    9331335
  • 财政年份:
    2013
  • 资助金额:
    $ 57.58万
  • 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
  • 批准号:
    8906838
  • 财政年份:
    2013
  • 资助金额:
    $ 57.58万
  • 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
  • 批准号:
    8485362
  • 财政年份:
    2013
  • 资助金额:
    $ 57.58万
  • 项目类别:
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis
HIV 相关口腔疣和念珠菌病中的口腔微生物组
  • 批准号:
    8739282
  • 财政年份:
    2013
  • 资助金额:
    $ 57.58万
  • 项目类别:
CD8 Tcells and Tissue E-cadherin in Host Defense Against Oral Candidiasis in HIV
CD8 T 细胞和组织 E-钙粘蛋白在宿主防御 HIV 口腔念珠菌病中的作用
  • 批准号:
    8528024
  • 财政年份:
    2012
  • 资助金额:
    $ 57.58万
  • 项目类别:
Mentoring Oral Health Research in Louisiana
指导路易斯安那州的口腔健康研究
  • 批准号:
    7893967
  • 财政年份:
    2009
  • 资助金额:
    $ 57.58万
  • 项目类别:
LSU DENTAL COBRE: ADMINISTRATIVE CORE
LSU DENTAL COBRE:管理核心
  • 批准号:
    7720556
  • 财政年份:
    2008
  • 资助金额:
    $ 57.58万
  • 项目类别:
LSU DENTAL COBRE: ADMINISTRATIVE CORE
LSU DENTAL COBRE:管理核心
  • 批准号:
    7610696
  • 财政年份:
    2007
  • 资助金额:
    $ 57.58万
  • 项目类别:
LSU DENTAL COBRE: ADMINISTRATIVE CORE
LSU DENTAL COBRE:管理核心
  • 批准号:
    7382150
  • 财政年份:
    2006
  • 资助金额:
    $ 57.58万
  • 项目类别:
8th ASM Conference on Candida and Candidiasis
第八届 ASM 念珠菌和念珠菌病会议
  • 批准号:
    7058480
  • 财政年份:
    2006
  • 资助金额:
    $ 57.58万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 57.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了